跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CEFARAP - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
CEFARAP
Approved
STANDARD
CEFARAP
Azarias Pharmaceutical Laboratories Inc
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7463d3c9884ee50e
Company
Azarias Pharmaceutical Laboratories Inc
Type
Standard
Approval Details
Approval Id
7463d3c9884ee50e
Drug Approval Philippines Name
CEFARAP
Product Name
CEFARAP
Registration Number
DRP-12408-01
Brand Name
CEFARAP
Generic Name
Cefalexin (as monohydrate)
Dosage Form
Powder for Suspension
Dosage Strength
250 mg/5 mL
Manufacturer
Azarias Pharmaceutical Laboratories Inc
Distributor
St. Raphael Archangel Pharmaceutical Product Distribution
Issuance Date
28 September 2022
Expiry Date
21 July 2027
Pharmacologic Category
Antibacterial (First Generation Cephalosporins)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7463d3c9884ee50e
Type
Standard
Back to Philippines FDA Approvals